Clinical characteristics of human fascioliasis in Egypt

• Published in: Scientific reports 2023-09, Vol.13 (1), p.16254-16254, Article 16254
• Main Authors: Ibrahim, Nagat, Abdel Khalek, Ekram M., Makhlouf, Nahed A., Abdel-Gawad, Muhammad, Mekky, Mohamed, Ramadan, Haidi Karam-Allah, Abu-Elfatth, Ahmed, El-Latif, Naglaa Abd, Hassan, Marwa Khalaf, Eldeeb, Rabab, Abdelmalek, Mohamed, Abd-elsalam, Sherief, Attia, Hanaa, Mohammed, Ahmed Qasem, Aboalam, Hani, Farouk, Mahmoud, Alboraie, Mohamed
• Format: Article
• Language: English
• Subjects: 631/601; 692/4020; 692/699; Bilirubin; Clinical outcomes; Eosinophilia; Epidemiology; Fever; Hemoglobin; Humanities and Social Sciences; Lesions; Leukocytes (eosinophilic); Liver; Medical records; multidisciplinary; Pain; Patients; Rural areas; Science; Science (multidisciplinary)
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-023-42957-7

There is a lack of epidemiological data on fascioliasis in Egypt regarding disease characteristics and treatment outcomes across different governorates. We aimed to identify the demographic, epidemiologic, clinical, laboratory, and radiological characteristics and treatment outcomes of patients diagnosed with fascioliasis in Egypt. Data on human fascioliasis were collected retrospectively from patients’ medical records in the period between January 2018 and January 2020. The study included 261 patients. More than 40% of enrolled patients were in the age group of 21–40 years old. Geographically, 247 (94.6%) were from Assiut Governorate with 69.3% were from rural areas. The most frequent symptoms were right upper quadrant pain (96.9%), and fever (80.1%). Eosinophilia was found in 250 cases (95.8%). Hepatic focal lesions were detected in 131 (50.2%); out of them 64/131 (48.9%) had a single lesion. All patients received a single dose of 10 mg/kg of triclabendazole, 79.7% responded well to a single dose, while in 20.3% a second ± a third dose of treatment was requested. After therapy, there was a reduction in leucocytes, Fasciola antibodies titer, eosinophilic count, bilirubin, and liver enzymes with an increase in hemoglobin level. According to our findings, a high index of suspicion should be raised in cases with fever, right upper abdominal pain, and peripheral eosinophilia, and further imaging workup is mandated to detect hepatic focal lesions. Prompt treatment by triclabendazole can serve as a standard-of-care regimen even for suspected cases.